Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ITGB3BP Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5100723
Description
Antibody detects endogenous levels of total CENPR.
ITGB3BP is a transcription coregulator that can have both coactivator and corepressor functions. Isoform 1, but not other isoforms, is involved in the coactivation of nuclear receptors for retinoid X (RXRs) and thyroid hormone (TRs) in a ligand-dependent fashion. ITGB3BP acts as a transcriptional corepressor via its interaction with the NFKB1 NF-kappa-B subunit, possibly by interfering with the transactivation domain of NFKB1. It induces apoptosis in breast cancer cells, but not in other cancer cells, via a caspase-2 mediated pathway that involves mitochondrial membrane permeabilization but does not require other caspases. ITGB3BP may also act as an inhibitor of cyclin A-associated kinase. ITGB3BP may be involved in incorporation of newly synthesized CENPA into centromeres via its interaction with the CENPA-NAC complex.
Specifications
ITGB3BP | |
Polyclonal | |
Unconjugated | |
ITGB3BP | |
4930471O16Rik; AU022583; beta 3 endonexin; beta-3-endonexin; beta3-endonexin; Cenpr; CENP-R; Centromere protein R; HSU37139; integrin beta 3 binding protein (beta3-endonexin); integrin beta-3-binding protein; integrin subunit beta 3 binding protein; Itgb3bp; Nrif3; Nuclear receptor-interacting factor 3; TAP20 | |
Rabbit | |
Affinity Chromatography | |
RUO | |
23421, 67733 | |
-20°C | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
Q13352, Q9CQ82 | |
ITGB3BP | |
A synthesized peptide derived from human ITGB3BP(Accession Q13352), corresponding to amino acid residues T36-F86. | |
100 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction